Back to search

Article

The Limits of Molecular Signatures for Pancreatic Ductal Adenocarcinoma Subtyping

2022-05-16

Abstract excerpt

<h4>ABSTRACT</h4> Molecular signatures have been suggested as biomarkers to classify pancreatic ductal adenocarcinoma (PDAC) into two, three or four subtypes. Since the robustness of existing signatures is controversial, we performed a systematic evaluation of three established signatures for PDAC stratification across eight publicly available datasets. Clustering revealed inconsistency of subtypes across indepen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1fc5367d-365e-58ae-b56b-8e4036268a8e
DOI
10.1101/2022.05.16.491983
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Limits of Molecular Signatures for Pancreatic Ductal Adenocarcinoma SubtypingDOI 10.1101/2022.05.16.491983
Select a neighboring publication to make it the new centre.